The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumonia

European Respiratory Journal

Volumn 41, Issue 4, 2013, Pages 935-942

  Schouten, Marcel ^a   De Boer, J Daan ^a   Van't Veer, Cornelis ^a   Roelofs, Joris J T H ^a   Meijers, Joost C M ^a   Levi, Marcel ^a   Conway, Edward M ^b   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Coagulation; Inflammation; Sepsis; Streptococcus pneumoniae

Indexed keywords

CHEMOKINE; CYTOKINE; THROMBOMODULIN;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BLOOD; CONTROLLED STUDY; DISEASE DURATION; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNOREGULATION; KNOCKOUT MOUSE; LIVER; MOUSE; NEUTROPHIL INFLUX; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; WILD TYPE;

ANIMALS; BACTERIAL LOAD; BLOOD COAGULATION; BRONCHOALVEOLAR LAVAGE; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION; LECTINS; LIVER; LUNG; MICE; MICE, INBRED C57BL; NEUTROPHILS; PNEUMONIA, PNEUMOCOCCAL; PROTEIN INTERACTION DOMAINS AND MOTIFS; SEPSIS; THROMBOMODULIN;

EID: 84875864582     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00015212     Document Type: Article

References (25)

1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27-S72.
2. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Wolfe S, Hamborsky J, eds. 12th Edn. Washington DC, public Health Foundation, 2012.
3. Balakrishnan I, Crook P, Morris R, et al. Early predictors of mortality in pneumococcal bacteraemia. J Infect 2000; 40: 256-261.
4. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31: 347-382.
5. Conway EM. Thrombomodulin and its role in inflammation. Semin Immunopathol 2012; 34: 107-125.
6. Ito T, Maruyama I. Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation. J Thromb Haemost 2011; 9: Suppl. 1, 68-73.
7. Takagi T, Taguchi O, Toda M, et al. Inhibition of allergic bronchial asthma by thrombomodulin is mediated by dendritic cells. Am J Respir Crit Care Med 2011; 183: 31-42.
8. Schouten M, Wiersinga WJ, Levi M, et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83: 536-545.
9. Danese S, Vetrano S, Zhang L, et al. The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications. Blood 2010; 115: 1121-1130.
10. Weiler H. Regulation of inflammation by the protein C system. Crit Care Med 2010; 38: Suppl. 2, S18-S25.
11. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995; 270: 14477-14484.
12. Myles T, Nishimura T, Yun TH, et al. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J Biol Chem 2003; 278: 51059-51067.
13. Conway EM, Van de Wouwer M, Pollefeyt S, et al. The lectin-like domain of thrombomodulin confers protection from neutrophilmediated tissue damage by suppressing adhesion molecule expression via nuclear factor kB and mitogen-activated protein kinase pathways. J Exp Med 2002; 196: 565-577.
14. Geudens N, Van de Wouwer M, Vanaudenaerde BM, et al. The lectin-like domain of thrombomodulin protects against ischaemiareperfusion lung injury. Eur Respir J 2008; 32: 862-870.
15. Van de Wouwer M, Plaisance S, De Vriese A, et al. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J Thromb Haemost 2006; 4: 1813-1824.
16. Kawanami O, Jin E, Ghazizadeh M, et al. Heterogenous distribution of thrombomodulin and von Willebrand factor in endothelial cells in the human pulmonary microvessels. J Nihon Med Sch 2000; 67: 118-125.
17. Ford VA, Stringer C, Kennel SJ. Thrombomodulin is preferentially expressed in Balb/c lung microvessels. J Biol Chem 1992; 267: 5446-5450.
18. Rijneveld AW, Weijer S, Florquin S, et al. Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004; 103: 1702-1709.
19. Schouten M, van' t Veer C, Roelofs JJ, et al. Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study. Crit Care 2010; 14: R145.
20. Rijneveld AW, Levi M, Florquin S, et al. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol 2002; 168: 3507-3511.
21. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 2008; 14: 558-564.
22. Nishimura T, Myles T, Piliponsky AM, et al. Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo. Blood 2007; 109: 1992-1997.
23. Brown JS, Hussell T, Gilliland SM, et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 2002; 99: 16969-16974.
24. Shi CS, Shi GY, Hsiao SM, et al. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood 2008; 112: 3661-3670.
25. Saito H, Maruyama I, Shimazaki S, et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 2007; 5: 31-41.